Program Overview: A Second Year of Innovation
Northwestern Medicine and Techstars have announced five new startups for the 2026 class of their joint healthcare accelerator program. Now in its second year, the initiative continues to push boundaries across clinical care, digital health, therapeutics, and artificial intelligence. The program hosts early-stage companies at Northwestern Medicine’s Mansueto Innovation Institute in Chicago for a focused, 13-week, mentorship-driven experience.
Furthermore, this year’s selection process drew from a highly competitive pool of applicants. The result is a cohort tackling some of healthcare’s most pressing challenges — from cancer survivorship to AI-driven pathology. Together, these startups represent the next wave of health technology innovation building toward better patient outcomes.
Meet the 2026 Startup Cohort
The 2026 class features five companies, each targeting a distinct gap in the healthcare landscape. Here is a closer look at each of them.
Arul Health: Reimagining Cancer Survivorship Care
Based in Boston, Massachusetts, Arul Health offers a digital platform built specifically by cancer survivors. Its mission centers on elevating the quality of survivorship care through personalized psycho-oncology therapy, virtual peer support, and integrative medicine guidance. Consequently, patients gain access to comprehensive, survivor-informed support long after their primary treatment ends.
ImmPro: Advancing Proteomics for Biopharma
Chicago-based ImmPro focuses on top-down proteomics for biopharmaceutical development. Moreover, the company provides comprehensive, single-particle protein analysis to characterize intact proteoforms and gene therapy vectors. This approach supports drug developers in understanding complex biologics with greater precision.
AI-Powered Clinical Compliance
Another selected startup is developing a clinical compliance tool that uses artificial intelligence to ensure real-time protocol adherence. Instead of relying on retrospective audits, this solution monitors clinical workflows as they happen. As a result, healthcare providers can address deviations immediately and reduce the risk of protocol-related errors.
Video Game Therapy for Mental Health
One of the most distinctive additions to the cohort is a mental health therapeutics startup building video game-based interventions for depression. Rather than traditional therapy formats, the company creates engaging, evidence-informed digital experiences designed to improve mood and mental resilience. This signals a growing shift toward non-pharmacological, accessible mental health solutions.
Digital Pathology at Scale
The final startup in the 2026 class is working to expand access to AI-powered digital pathology. By automating and enhancing diagnostic image analysis, this company aims to bring faster, more accurate pathology services to a wider range of healthcare settings. Additionally, this innovation holds strong potential for underserved communities where specialist access is limited.
What the Program Offers Founders
Startups selected for the Northwestern Medicine and Techstars Healthcare Accelerator receive far more than office space. Each company gains access to funding, hands-on mentorship, and structured training. They also benefit from the combined networks of Techstars and Northwestern Medicine — two organizations with deep roots in both healthcare delivery and startup development.
The accelerator’s home at the Mansueto Innovation Institute places founders in direct contact with Northwestern’s clinical teams. This proximity allows for rapid iteration and real-world validation of their technologies. In addition, the program’s focus on enterprise healthcare gives startups a strategic advantage when approaching hospital systems and health networks.
Leadership Vision Behind the Accelerator
Doug King, Chief Digital and Information Officer at Northwestern Medicine, emphasized the program’s collaborative spirit. He noted that the inaugural year demonstrated what becomes possible when visionary entrepreneurs partner directly with clinical teams. Moving forward, he expressed enthusiasm for exploring emerging technologies and their long-term impact on patient care.
Brad Schnitzer, Managing Director of the accelerator at Techstars, echoed that sentiment. He highlighted the high standard set by the inaugural class and expressed confidence in the new cohort’s potential. Above all, he credited Northwestern Medicine’s hands-on commitment as a defining factor in preparing startups to succeed in the enterprise healthcare space.
Demo Day and What Comes Next
Demo Day for the 2026 class is scheduled for early June 2026. At that event, the five startups will pitch directly to a community of mentors, investors, and healthcare industry leaders. This milestone marks the culmination of 13 weeks of intensive development, feedback, and refinement.
The accelerator’s second year reflects a broader strategic direction for Northwestern Medicine. The health system recognizes that solving complex healthcare problems requires external innovation partners. Therefore, by continuing this program, Northwestern is investing not just in individual startups but in the future of healthcare delivery itself.
